We celebrated a meaningful moment in the #IJGCfamily story at the #IGCS2026 Annual Global Meeting.💖 Pedro Ramirez @pedroramirezMD presented his report as Editor-in-Chief and took us on a journey through the history, growth and achievements of our journal. A legacy shaped by vision, dedication and an extraordinary global community. We were also thrilled to witness René Pareja @RParejaGineOnco officially receive the role of Editor-in-Chief. This is not just a transition, but the continuation of a shared mission: advancing knowledge, education, and care in gynecologic oncology. Thank you Pedro, for your remarkable leadership and for all that you have brought to IJGC.🤩 Congratulations René, we are excited for the next chapter. 💙 @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Suvidyasingh20 @ohadfeld

Each year, @USNews publishes a list of the top ranked hospitals in the U.S. This year, we’re both honored and excited that Houston Methodist Hospital is ranked No. 7 in the nation for Obstetrics & Gynecology.

Dr. @pedroramirezMD moderates a multidisciplinary panel discussion about the latest advances in de-escalating treatment for cervical, uterine and ovarian cancers featuring Drs. Jessica Floyd, Karolina Kilowski and @ZandBehrouz. Watch the full discussion: spr.ly/6014BDdXM4

We're thrilled to see IJGC reach an impact factor of 5.4 — a reflection of the influence and visibility of IJGC. We are so proud of the high quality content published and cited by other researchers. This is a milestone worth celebrating, congrats to Pedro Ramirez, Editor-in-Chief, and the entire editorial team. We are grateful for the support from our publisher Elsevier. We look forward to building on this momentum!

💉 Could #GLP1 RAs help reduce #cancer risk? 🆕 observational data found a significantly lower incidence of obesity-related cancers among GLP-1 RA users, with the greatest reduction seen with tirzepatide. 🔹 Aparna A. Kamat, MD | @Annals_Oncology 🔗 ascopost.com/news/june-2026/…

Meet another member of our 2026 #EditorialFellows cohort! We’re excited to welcome Chiara Innocenzi @Chiara_4997, a fourth-year resident in Obstetrics and Gynecology at Fondazione Policlinico Universitario A. Gemelli 🇮🇹 Thrilled to have you join us, Chiara!🌟 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde

🌟 Meet our #IJGC #EditorialFellow! Christina Köhler, MD 🇩🇪 joins the IJGC editorial fellowship, bringing expertise in tumor immunology and ovarian cancer research. From clinical training in Stuttgart to cutting-edge research at the German Cancer Research Center—shaping the future of #GynOnc 🔬 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

🌟 Meet our 2026 IJGC #EditorialFellow! We’re excited to introduce Dr Eleonora Panizzolo (@ElePanizzolo) 🇮🇹, a passionate gynecologist from Italy! Welcome to the #IJGCfamily! 💙 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde #IJGConline #Research #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

Our Houston Methodist residents @AlwynDO and @AIBagdasaryants presenting their work at #SGOAM2026. Great to see them asking the right questions and see this level of work early in their training. 👏 @MethodistHosp @pedroramirezMD